CN Patent

CN114222569A — 特发性少汗症的治疗

Assigned to National Skin Center · Expires 2022-03-22 · 4y expired

What this patent protects

本发明提供了用于特发性少汗症的新的治疗。在一种实施方式中，所述治疗包括向有需要的患者给药药学上有效量的类视黄醇。优选地，类视黄醇是异维A酸或阿维A。

USPTO Abstract

本发明提供了用于特发性少汗症的新的治疗。在一种实施方式中，所述治疗包括向有需要的患者给药药学上有效量的类视黄醇。优选地，类视黄醇是异维A酸或阿维A。

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN114222569A
Jurisdiction: CN
Classification: —
Expires: 2022-03-22
Drug substance claim: No
Drug product claim: No
Assignee: National Skin Center
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.